Testing effectiveness (Phase 2)WithdrawnNCT04492436
What this trial is testing
A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
Who this might be right for
Chemotherapy-induced Peripheral Neuropathy
Veloxis Pharmaceuticals